Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.040
-0.160 (-7.27%)
At close: Jan 6, 2026, 4:00 PM EST
2.080
+0.040 (1.96%)
After-hours: Jan 6, 2026, 4:50 PM EST
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $196.38 million as of January 6, 2026. Its market cap has increased by 46.10% in one year.
Market Cap
196.38M
Enterprise Value
64.16M
1-Year Change
46.10%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has decreased from $235.53M to $196.38M, a decrease of -16.62%. That is a compound annual growth rate of -2.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 211.78M | 0.46% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |